![](images/icon_path.jpg)
![](images/icon_path.jpg)
ÀÇ·áÁø¼Ò°³
![](images/doctor_kms.jpg)
ºÎÀξÏ, ÀڱñÙÁ¾, ³¼ÒÁ¾¾ç, ºñÁ¤»óÀڱðæºÎ¼¼Æ÷Áø
¿ø±¤´ë ÀÇ°ú´ëÇÐ Á¹¾÷
ÀÎÁ¦´ë »êºÎÀΰúÇÐ ¼®»ç ¼ö·á
¼¿ï´ëÇб³ ´ëÇпø ÀÇÇйڻç
¼¿ï¹éº´¿ø »êºÎÀΰú Àü°øÀÇ ¼ö·á
ºÐ´ç¼¿ï´ëº´¿ø »êºÎÀΰú ÀüÀÓÀÇ
ºÐ´ç¼¿ï´ëº´¿ø »êºÎÀΰú Áø·áÀü¹®ÀÇ
°³²Â÷º´¿ø »êºÎÀΰú ±³¼ö
´ëÇѽɽŻêºÎÀΰúÇÐȸ
´ëÇÑ»êºÎÀΰúÇÐȸ
´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ëÇѺñ´¢ºÎÀΰúÇÐȸ
´ëÇѺÎÀξÏÁß°³¿¬±¸È¸
¼ö»ó°æ·Â¡¤³í¹®
1) Kim M, Cheol Lim M, Ji Nam E, Huang D, Kim S, Jong Yoo H, Lee YY, Chang YJ; on the behalf of the sub-committee of Hereditary Gynecologic Cancers in the Korean Society of Gynecologic Oncology (KSGO). Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey. J Genet Couns. 2021 Oct 21. doi: 10.1002/jgc4.1524. Online ahead of print.
2) Kim M, Lee N, Won S, Kim JH, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ. Lead time on confirmatory test after abnormal Pap test in the COVID-19 era. Medicine (Baltimore). 2021 Oct 1;100(39):e27327. doi: 10.1097/MD.0000000000027327.
3) Kim M, Kim H, Suh DH, Kim YB. Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study. Cancer Res Treat. 2020 Dec 10. doi: 10.4143/crt.2020.826. Online ahead of print.
4) Kim M, Suh DH, Lee KH, Eom KY, Lee JY, Lee YY, Hansen HF, Mirza MR, Kim JW. Major clinical research advances in gynecologic cancer in 2019. J Gynecol Oncol. 2020 May;31(3):e48.
5) Aoki ES, Yin R, Li K, Bhatla N, Singhal S, Ocviyanti D, Saika K, Suh M, Kim M(±³½Å), Termrungruanglert W. National screening programs for cervical cancer in Asian countries. J Gynecol Oncol. 2020 May;31(3):e55.
¿ù | È | ¼ö | ¸ñ | ±Ý | Åä | |||||
---|---|---|---|---|---|---|---|---|---|---|
¿ÀÀü | ¿ÀÈÄ | ¿ÀÀü | ¿ÀÈÄ | ¿ÀÀü | ¿ÀÈÄ | ¿ÀÀü | ¿ÀÈÄ | ¿ÀÀü | ¿ÀÈÄ | ¿ÀÀü |
Áø·á | ¼ö¼ú | Áø·á | Áø·á | Áø·á | ÈÞÁø | Áø·á | ¼ö¼ú | Áø·á | Áø·á | Áø·á |
- Áø·áÀÏÁ¤Àº ¼ö¼ú ¹× ÀÇ·áÁøÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î ÇØ´ç Áø·á°ú¿¡ ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù.(»êºÎÀΰú ¿Ü·¡ : 052-226-0239)